Comparison of Radiographic Fusion Rate and Clinical Outcome of ALIF and XLIF Performed With Either Recombinant Human Bone Morphogenetic Protein-2 or ViviGen®

Clinical trial NCT05238740 · RECRUITING

Trial details

NCT number: NCT05238740
Sponsor: Lindenhofgruppe AG
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Spondylosis Spondylolisthesis Degenerative Disc Disease

Start date: 2022-10-27
Primary completion: 2027-12-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.